Primedex to explore strategic options

Article

California imaging services provider Primedex announced last monththat it is exploring new options for the company, including possiblepartnerships or alliances. The announcement came as no great surprise, given recent Primedexhistory and the general

California imaging services provider Primedex announced last monththat it is exploring new options for the company, including possiblepartnerships or alliances.

The announcement came as no great surprise, given recent Primedexhistory and the general popularity of mergers and acquisitionsin the imaging service sector. Primedex nearly acquired San Diego'sMedical Imaging Centers of America in July, only to lose out toan 11th-hour bid by U.S. Diagnostic Labs. USDL has a deal pendingto acquire MICA's 17 centers for about $32 million (SCAN 7/31/96).

A merger in May with Diagnostic Imaging Services brought 10Southern California imaging centers, 15 ultrasound labs, and 13mobile ultrasound units into the Primedex fold. Before that deal,Los Angeles-based Primedex operated 19 California imaging centersthrough its RadNet subsidiary. Its Future Diagnostics subsidiaryarranges brokered imaging services for 180 imaging centers inthe state.

In a statement, Primedex president and CEO Dr. Howard Bergersaid that his company's board of directors had determined thatthe time is right to explore alternatives to enhance the company'svalue and position. He declined to elaborate on the announcementwhen contacted by SCAN.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.